- Home
- AXSM vs QBTS Comparison
AXSM vs QBTS Comparison
Compare AXSM & QBTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AXSM | QBTS |
|---|---|---|
| Founded | 2012 | 1999 |
| Country | United States | United States |
| Employees | N/A | 388 |
| Industry | Biotechnology: Pharmaceutical Preparations | Retail: Computer Software & Peripheral Equipment |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.0B | 9.7B |
| IPO Year | 2015 | N/A |
Fundamental Metrics
Financial Performance| Metric | AXSM | QBTS |
|---|---|---|
| Price | $251.46 | $23.14 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 17 | 15 |
| Target Price | ★ $211.12 | $32.53 |
| AVG Volume (30 Days) | 592.3K | ★ 39.4M |
| Earning Date | 05-04-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 38.56 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $57.24 | $81.05 |
| Revenue Next Year | $55.88 | $93.13 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $96.09 | $12.75 |
| 52 Week High | $257.93 | $46.75 |
Technical Indicators
Market Signals| Indicator | AXSM | QBTS |
|---|---|---|
| Relative Strength Index (RSI) | 70.07 | 46.96 |
| Support Level | $148.87 | $17.51 |
| Resistance Level | N/A | $30.96 |
| Average True Range (ATR) | 8.48 | 2.45 |
| MACD | 0.46 | -0.60 |
| Stochastic Oscillator | 84.87 | 8.66 |
Price Performance
Historical ComparisonAbout AXSM Axsome Therapeutics Inc.
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products include AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.
About QBTS D-Wave Quantum Inc.
D-Wave Quantum Inc is in the development and delivery of quantum computing systems, software, and services, and it is the commercial supplier of quantum computers and the only company building both annealing quantum computers and gate-model quantum computers. It delivers customer value with practical quantum applications for problems as diverse as logistics, artificial intelligence, materials sciences, drug discovery, scheduling, cybersecurity, fault detection, and financial modeling. Its annealing quantum computers are accessible through the company's LeapTM cloud service.